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Cryptococcosis is an opportunistic yeast infection that is 
the most common systemic fungal infection in immuno-
compromised patients. Skin involvement is a feature in 
10–20% of cases of disseminated cryptococcal infection 
(1). We report here a case of a 63-year-old woman with 
Sézary syndrome (T4, N3, M0, B1) with an ulcerated 
preauricular tumour that developed during photopheresis 
with a combination of methotrexate and steroid treatment. 
We highlight the importance of differential diagnosis of 
cryptococcosis in the case of any atypical or non-healing 
lesions observed in an immunosuppressed patient.
CASe reporT
A 63-year-old Caucasian woman who had breast cancer and 
underwent mastectomy in 1989 followed by chemotherapy was 
diagnosed in 1998 with parapsoriasis through clinical signs and 
histological examination in the County Hospital. In 2001 she pre-
sented with generalized pruritus and erythroderma at our clinic. 
She responded poorly to oral psoralen and ultraviolet A (pUVA) 
therapy. In 2002 clinical signs (weakness, general condition, 
intermittent fever) were suspicious for Sézary syndrome or Cuta-
neous T-cell lymphoma. Sézary syndrome was confirmed in 2003 
by peripheral blood examination (28% CD4+, CD7– cells), and 
electron-microscopy of the lymph nodes from two biopsies. At that 
time skin biopsies showed mild acanthosis, parakeratosis and some 
perivascular mononuclear cell infiltrate in the papillary dermis, 
whereas bone marrow biopsies were normal. After ineffective 
treatment with local steroid and bath pUVA she received systemic 
steroid plus azathioprine treatment (1 mg/kg) with moderate effect. 
The CD4+ cell percentage increased to 84%, consisting of 69% 
CD4+/CD7– cells. Due to the systemic appearance of the disease 
(Ann Arbor stage IV) in April 2004 one cycle of cyclophosphamide 
+ vincristine + prednisolone (CVp) therapy was given in the De-
partment of Internal Medicine, with poor response. She was treated 
with oral steroid with moderate effect. At this point another lymph 
node biopsy was performed that confirmed Sézary syndrome, 
and further treatment included total body electron irradiation 
in 2005 at the oncology Center in Budapest. From February to 
September 2007 photopheresis in combination with methotrexate 
and steroid treatment had no effect on her symptoms and the 
skin infiltration increased, therefore methylprednisone, 8–16 mg 
daily, was administered constantly to control the symptoms (Fig. 
1A). In May 2007, she developed a small hyperaemic nodule in 
the preauricular region, suspicious for basal cell carcinoma. We 
planned to perform a biopsy from the lesion, but the patient did 
not agree to the procedure at that time because of its localization. 
By August, at the next check-up, the lesion had a size of 2 × 3 cm 
with minor ulceration, and increased continuously in size to 5 × 7 
cm by october (Fig. 1B). Differential diagnosis was performed 
for basal cell carcinoma, atypical mycobacteriosis, deep fungal 
infection, pyoderma, exulcerated lymphoma, spinocellular car-
cinoma, pyoderma gangrenosum, leishmaniasis, insect bite, burn 
injury, trauma, and artefact. Biopsy specimens revealed necrotic 
epidermis, ulceration, a granulomatous infiltrate in the dermis, and 
numerous round organisms with capsules measuring 2 ± 10 μm in 
diameter present both extracellularly and within the vacuolated 
spaces of macrophages (Fig. 1C). The organisms were also stai-
ned with Giemsa and showed periodic acid-Schiff (pAS)-positive 
reaction (Fig. 1D and e). Serology for Cryptococcus antigen was 
positive in the blood. Chest X-ray and computed tomography (CT) 
revealed Cryptococcus infection of the lung, cerebrospinal fluid 
was negative for the presence of Cryptococcus and there were no 
signs or symptoms of meningeal involvement.
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Fig. 1. (A) Generalized exfoliative erythroderma 
of the patient with advanced Sézary syndrome 
before extending photopheresis treatment with 
a combination of methotrexate and steroid. (B) 
Ulcer affecting the pre-auricular region mimicking 
basal cell carcinoma that developed during 
immunosuppressive treatment. Note the biopsy 
site (circle). (C) Histological examination of the 
skin biopsy from the ulcer showed innumerable 
thick capsulated round organisms measuring 
2 ± 10 μm both extracellularly and within the 
vacuolated spaces of macrophages (red arrows) 
(haematoxylin and eosin; original magnification 
× 40). (D) Cryptococcal organisms stain red with 
periodic acid-Schiff (pAS) (black arrows) (original 
magnification × 100) and (E) blue with Giemsa stain 
(diamond arrows) (original magnification × 40). 
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In october 2007 the patient started receiving intravenous ampho-
tericin B and fluconazole. Despite all our efforts Cryptococcus 
antigenaemia was still detected. The patient died 6 weeks later 
from acute cardiac and renal failure. Autopsy revealed cutaneous 
cryptococcal infection in the skin of the submammal region of the 
thorax and in the lungs.
DISCUSSIoN
Cryptococcal species are yeast-like fungi. Based on 
their virulence they are classified as pathogenic or 
non-pathogenic. Classically, C. neoformans is the only 
pathogenic cryptococcal species present in high con-
centrations in pigeon faeces, but also in soil, fruit, and 
other sources in nature, such as eucalypt reservoirs. It 
includes four distinguishable serotypes: A (C. neofor-
mans var. grubii) has a worldwide distribution; D (C. 
neoformans var. neoformans) found mostly in europe; 
and B and C (C. neoformans var. gattii), which are 
limited to tropical and subtropical areas (2, 3). 
Cryptococcus infection is acquired by inhalation and 
resides in the lung, mostly in the immunocompromised 
host, as was the case in our patient, due to Sezary syn-
drome and continuous steroid immunosuppressive treat-
ment with photopheresis extended with a combination 
of methotrexate. Infection can also involve patients with 
intact immune systems who are predominantly infected 
with C. neoformans var. gattii (4). The infection can re-
solve or disseminate, mostly spreading to the meninges, 
but bones, viscera and the skin can also be involved. In 
the diagnoses of Cryptococcus infection, culture from 
smears of body fluids, secretions, exudates, or other 
specimens is definitive, but X-ray and serological exa-
mination are also of importance. 
Involvement of the skin can result in a great variety 
of lesions, most commonly affecting the face and neck, 
from papules, nodules, acneiform lesions, granulomas, 
herpetiform vesicles, abscesses, and ulcers, resembling 
other cutaneous disease, such as molluscum contagio-
sum, vasculitis, Kaposi’s sarcoma, varicella, basal cell 
carcinoma, cellulitis, cutaneous ulceration, atypical 
mycobacteriosis and whitlow (5–8). The two forms 
of histological manifestation are gelatinous and gra-
nulomatous reactions. While the granulomatous type 
results in pronounced tissue reaction, with histiocytes, 
giant cells, lymphocytes, and fibroblasts, with a low 
number of yeasts, that vary in size from 2 to 20 μm, in 
the gelatinous type, masses of organisms occur, with the 
accumulation of cryptococcal capsular polysaccharide 
causing mucoid degeneration of the invaded tissue, with 
only minimal signs of inflammation (6).
Treatment of the systemic infection includes appropriate 
antifungal drugs, in which the mainstay is intravenous 
amphotericin B in combination with flucytosine, which is 
often followed by fluconazole for many months or, depen-
ding on the patient’s immune status, even life-long. If flu-
conazole is not available or is contraindicated, acceptable 
alternatives include itraconazole, or extended-spectrum 
azoles (voriconazole and posaconazole). occasionally, 
localized cryptococcal infections of the lung not respon-
ding to medical therapy may require surgical resection for 
cure (9). In the case of cutaneous Cryptococcus infection 
successful treatment with oral fluconazole alone has also 
been reported, and incision, with local irrigation and de-
bridement, topical application of anti-inflammatory agents 
and antifungal agents was also recommended (8, 10).
our case illustrates the importance of serological tests 
with histological examination, and pathogen-culturing 
from any atypical or non-healing lesions observed in im-
munocompromised patients for an accurate diagnosis of 
opportunistic infection. Importantly, a primary infection of 
the lung and disseminated infection involving the central 
nervous system may be present with dermatological rather 
than pulmonary or neurological manifestations (11). 
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